Government Owned Invention Available for License: A Conserved Viral Peptide for Use in Cancer Immunotherapy
Official abstract: The National Cancer Institute (NCI) seeks research co- development partners and/or licensees for viral peptide (CE1)-based therapeutics for HCC prevention and treatment.